Atea Pharmaceuticals (AVIR)
(Delayed Data from NSDQ)
$3.67 USD
-0.15 (-3.93%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.68 +0.01 (0.27%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.50 |
EPS Last Quarter | -0.48 |
Last EPS Surprise | 37.66% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.22 |
Next Year | -1.80 |
EPS (TTM) | -2.10 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 20.11M |
# of Estimates | NA | NA | NA | 3 |
High Estimate | NA | NA | NA | 37.59M |
Low Estimate | NA | NA | NA | 1.51M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.50 | -0.50 | -2.22 | -1.80 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.43 | -0.45 | -2.11 | -1.92 |
High Estimate | -0.43 | -0.45 | -2.11 | -1.67 |
Low Estimate | -0.56 | -0.54 | -2.32 | -1.92 |
Year ago EPS | -0.40 | -0.47 | -1.63 | -2.22 |
Year over Year Growth Est. | -25.00% | -6.38% | -36.20% | 18.92% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 2 | 2 | 2 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.50 | -0.50 | -2.22 | -1.80 |
7 Days Ago | -0.59 | -0.71 | -2.55 | -2.58 |
30 Days Ago | -0.59 | -0.71 | -2.55 | -2.58 |
60 Days Ago | -0.63 | -0.63 | -2.79 | -2.98 |
90 Days Ago | -0.63 | -0.63 | -2.79 | -2.98 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.50 | -0.50 | -2.22 | -1.80 |
Zacks Consensus Estimate | -0.50 | -0.50 | -2.22 | -1.80 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.48 | -0.75 | -0.47 | -0.40 | NA |
Estimate | -0.77 | -0.61 | -0.44 | -0.46 | NA |
Difference | 0.29 | -0.14 | -0.03 | 0.06 | 0.05 |
Surprise | 37.66% | -22.95% | -6.82% | 13.04% | 5.23% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more